tiprankstipranks
Celon Pharma SA (PL:CLN)
:CLN
Poland Market
CLN
Celon Pharma SA
RESEARCH TOOLSreports
Want to see PL:CLN full AI Analyst Report?

Celon Pharma SA (CLN) Ratios

0 Followers

Celon Pharma SA Ratios

PL:CLN's free cash flow for Q4 2025 was zł-0.07. For the 2025 fiscal year, PL:CLN's free cash flow was decreased by zł and operating cash flow was zł-0.14. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 1.62 1.62 1.84 2.20 2.04
Quick Ratio
 1.20 1.20 1.51 1.89 1.71
Cash Ratio
 0.31 0.31 0.10 0.37 0.71
Solvency Ratio
 -0.44 -0.44 0.18 0.18 0.04
Operating Cash Flow Ratio
 0.38 0.38 -0.13 -0.10 -0.04
Short-Term Operating Cash Flow Coverage
 2.72 2.72 -7.41 -0.65 0.00
Net Current Asset Value
zł 27.80Mzł 27.80Mzł 61.84Mzł 66.00Mzł 108.29M
Leverage Ratios
Debt-to-Assets Ratio
 0.04 0.04 0.03 0.04 0.04
Debt-to-Equity Ratio
 0.05 0.05 0.04 0.06 0.06
Debt-to-Capital Ratio
 0.05 0.05 0.04 0.05 0.05
Long-Term Debt-to-Capital Ratio
 <0.01 <0.01 0.00 0.00 0.00
Financial Leverage Ratio
 1.26 1.26 1.22 1.28 1.27
Debt Service Coverage Ratio
 -2.68 -2.98 4.97 1.59 3.88
Interest Coverage Ratio
 -12.77 -35.54 -14.89 -10.22 -41.75
Debt to Market Cap
 <0.01 <0.01 <0.01 0.02 0.00
Interest Debt Per Share
 0.40 0.38 0.37 0.55 0.56
Net Debt to EBITDA
 0.04 0.04 0.58 -0.21 -6.02
Profitability Margins
Gross Profit Margin
45.75%-18.82%64.23%68.76%58.95%
EBIT Margin
-22.35%-27.06%-20.89%-8.09%-21.48%
EBITDA Margin
-4.96%-4.99%8.47%15.29%5.76%
Operating Profit Margin
-16.44%-27.06%-20.84%-12.73%-43.08%
Pretax Profit Margin
-27.77%-28.11%-22.29%-9.33%-22.51%
Net Profit Margin
-37.41%-37.83%-19.50%-13.15%-24.26%
Continuous Operations Profit Margin
-37.41%-37.83%-19.50%-13.15%-24.26%
Net Income Per EBT
134.75%134.59%87.50%140.85%107.77%
EBT Per EBIT
168.90%103.88%106.95%73.30%52.24%
Return on Assets (ROA)
-17.29%-17.35%-6.33%-4.94%-6.45%
Return on Equity (ROE)
-20.32%-21.85%-7.74%-6.31%-8.19%
Return on Capital Employed (ROCE)
-8.81%-14.40%-8.06%-5.64%-14.16%
Return on Invested Capital (ROIC)
-8.62%-14.09%-6.92%-5.42%-13.63%
Return on Tangible Assets
-17.90%-17.96%-6.43%-5.07%-6.70%
Earnings Yield
-6.86%-7.24%-2.48%-3.50%-5.49%
Efficiency Ratios
Receivables Turnover
 4.05 4.02 4.01 4.43 4.80
Payables Turnover
 6.69 14.61 4.03 6.36 3.80
Inventory Turnover
 4.37 9.55 2.16 2.53 1.73
Fixed Asset Turnover
 0.70 0.69 0.57 0.64 0.53
Asset Turnover
 0.46 0.46 0.32 0.38 0.27
Working Capital Turnover Ratio
 6.27 3.74 2.00 1.91 1.03
Cash Conversion Cycle
 118.99 104.00 169.22 169.16 190.82
Days of Sales Outstanding
 90.09 90.76 90.95 82.30 75.97
Days of Inventory Outstanding
 83.47 38.23 168.85 144.24 210.81
Days of Payables Outstanding
 54.57 24.99 90.58 57.38 95.96
Operating Cycle
 173.56 128.99 259.80 226.55 286.78
Cash Flow Ratios
Operating Cash Flow Per Share
 0.44 0.44 -0.22 -0.16 -0.09
Free Cash Flow Per Share
 -0.57 -0.57 -0.65 -0.81 -0.76
CapEx Per Share
 1.01 1.01 0.43 0.64 0.66
Free Cash Flow to Operating Cash Flow
 -1.28 -1.28 3.01 4.95 8.21
Dividend Paid and CapEx Coverage Ratio
 0.44 0.44 -0.42 -0.22 -0.10
Capital Expenditure Coverage Ratio
 0.44 0.44 -0.50 -0.25 -0.14
Operating Cash Flow Coverage Ratio
 1.26 1.26 -0.67 -0.32 -0.18
Operating Cash Flow to Sales Ratio
 0.11 0.11 -0.06 -0.04 -0.03
Free Cash Flow Yield
-2.65%-2.79%-2.46%-5.11%-5.40%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -14.47 -13.81 -40.32 -28.61 -18.21
Price-to-Sales (P/S) Ratio
 5.41 5.22 7.86 3.76 4.42
Price-to-Book (P/B) Ratio
 3.15 3.02 3.12 1.81 1.49
Price-to-Free Cash Flow (P/FCF) Ratio
 -37.42 -35.85 -40.70 -19.57 -18.53
Price-to-Operating Cash Flow Ratio
 47.98 45.92 -122.50 -96.78 -152.17
Price-to-Earnings Growth (PEG) Ratio
 0.17 -0.11 -2.02 1.00 -0.09
Price-to-Fair Value
 3.15 3.02 3.12 1.81 1.49
Enterprise Value Multiple
 -109.18 -104.55 93.41 24.39 70.74
Enterprise Value
 1.15B 1.10B 1.40B 797.88M 659.28M
EV to EBITDA
 -109.95 -104.55 93.41 24.39 70.74
EV to Sales
 5.45 5.22 7.91 3.73 4.07
EV to Free Cash Flow
 -37.67 -35.84 -40.95 -19.40 -17.08
EV to Operating Cash Flow
 48.30 45.91 -123.26 -95.97 -140.24
Tangible Book Value Per Share
 6.82 6.82 8.32 8.43 8.95
Shareholders’ Equity Per Share
 6.74 6.74 8.48 8.73 9.40
Tax and Other Ratios
Effective Tax Rate
 -0.35 -0.35 0.13 -0.41 -0.08
Revenue Per Share
 3.92 3.90 3.36 4.19 3.17
Net Income Per Share
 -1.47 -1.47 -0.66 -0.55 -0.77
Tax Burden
 1.35 1.35 0.88 1.41 1.08
Interest Burden
 1.24 1.04 1.07 1.15 1.05
Research & Development to Revenue
 0.00 0.00 0.00 <0.01 <0.01
SG&A to Revenue
 0.18 0.00 0.14 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 <0.01 0.00 <0.01
Income Quality
 -0.29 -0.30 0.29 0.30 0.13
Currency in PLN